A Phase 1, Open Label, Placebo-Controlled Study to Evaluate the Effect of GSK1349572 on Iohexol and Para-Aminohippurate Clearance in Healthy Subjects

NCT01214993 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

38

Enrollment

INDUSTRY

Sponsor class

Conditions

Infections, Human Immunodeficiency Virus and Tuberculosis

Interventions

DRUG: GSK1349572
DRUG: Placebo
DRUG: Iohexol Injection
DRUG: Para-aminohippurate infusion

Sponsor

ViiV Healthcare

Collaborators

[object Object]
[object Object]